down arrow

Arvinas, Inc.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US04335A1051
USD
12.55
0.89 (7.63%)

Dec 04

NAS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
ANI Pharmaceuticals, Inc.
Aurinia Pharmaceuticals, Inc.
Twist Bioscience Corp.
Iovance Biotherapeutics, Inc.
Geron Corp.
Xencor, Inc.
Arvinas, Inc.
Vir Biotechnology, Inc.
Summit Therapeutics, Inc.
Disc Medicine, Inc.
Spyre Therapeutics, Inc.
Why is Arvinas, Inc. ?
1
Risky -
  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of -51.81%, its profits have risen by 100.7%
2
Consistent Underperformance against the benchmark over the last 3 years
  • Along with generating -51.81% returns in the last 1 year, the stock has also underperformed S&P 500 in each of the last 3 annual periods
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Arvinas, Inc. for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Arvinas, Inc.
-48.12%
-0.64
85.78%
S&P 500
13.22%
0.61
20.17%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
41.94%
EBIT Growth (5y)
2.78%
EBIT to Interest (avg)
-154.68
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-1.44
Sales to Capital Employed (avg)
6.12
Tax Ratio
0.15%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
0
ROE (avg)
0
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.83
EV to EBIT
11.39
EV to EBITDA
13.10
EV to Capital Employed
1.38
EV to Sales
-1.24
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
12.11%
ROE (Latest)
-10.12%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
Bearish
Bullish
Bollinger Bands
Bullish
Mildly Bearish
Moving Averages
Bullish (Daily)
KST
Bullish
Bearish
Dow Theory
No Trend
Mildly Bullish
OBV
No Trend
Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

19What is working for the Company
OPERATING CASH FLOW(Y)

Highest at USD -184.3 MM

NET PROFIT(HY)

At USD 22.7 MM has Grown at 121.7%

NET SALES(HY)

Higher at USD 211.2 MM

-10What is not working for the Company
NET PROFIT(Q)

At USD -60.2 MM has Fallen at -7,046.15%

DEBT-EQUITY RATIO (HY)

Highest at -139.68 %

OPERATING PROFIT(Q)

Lowest at USD -69.1 MM

PRE-TAX PROFIT(Q)

Lowest at USD -60.5 MM

EPS(Q)

Lowest at USD -0.84

Here's what is working for Arvinas, Inc.
Net Sales
At USD 211.2 MM has Grown at 107.47%
Year on Year (YoY)
MOJO Watch
Near term sales trend is very positive

Net Sales (USD MM)

Operating Cash Flow
Highest at USD -184.3 MM and Grown
In each year in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (USD MM)

Net Sales
Higher at USD 211.2 MM
than preceding 12 month period ended Jun 2025
MOJO Watch
In the half year the company has already crossed sales of the previous twelve months

Net Sales (USD MM)

Here's what is not working for Arvinas, Inc.
Pre-Tax Profit
At USD -60.5 MM has Fallen at -9,407.69%
over average net sales of the previous four periods of USD 0.65 MM
MOJO Watch
Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (USD MM)

Net Profit
At USD -60.2 MM has Fallen at -7,046.15%
over average net sales of the previous four periods of USD 0.87 MM
MOJO Watch
Near term Net Profit trend is very negative

Net Profit (USD MM)

Operating Profit
Lowest at USD -69.1 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is negative

Operating Profit (USD MM)

Pre-Tax Profit
Lowest at USD -60.5 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (USD MM)

EPS
Lowest at USD -0.84
in the last five periods
MOJO Watch
Declining profitability; company has created lower earnings for shareholders

EPS (USD)

Debt-Equity Ratio
Highest at -139.68 %
in the last five Semi-Annual periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."